ALTERNATIVE FINANCING FORMS
FOR ENTREPRENEURS AND INVESTORS
News
Photo: Kai Schadbach, LL.M., founder of Schadbach Rechtsanwälte in Frankfurt a. M. (Photo © Schadbach Rechtsanwälte

ETHYPHARM to buy Argatroban business from Mitsubishi Tanabe Pharma Group

Photo: Kai Schad­bach, LL.M., foun­der of Schad­bach Rechts­an­wälte in Frank­furt a. M. (Photo © Schad­bach Rechtsanwälte
17. July 2025

Frank­furt a. Main — The leading medium-sized inter­na­tio­nal phar­maceu­ti­cal company Ethy­ph­arm S.A.S., Saint-Clou­­d/France has signed a purchase agree­ment for the rights to the Euro­pean Arga­tro­ban busi­ness of Mitsu­bi­shi Tanabe Pharma Corpo­ra­tion, Osaka/Japan and other compa­nies of the Mitsu­bi­shi Tanabe Pharma Group. Arga­tro­ban mono­hy­drate is a selec­tive anti­throm­bin agent used in the treat­ment of hepa­rin-indu­­ced throm­bo­cy­to­pe­nia type II (HIT type II). Due to the company struc­tures, the comple­xity of the rights to the product and the invol­vement of other opera­tio­nal inter­me­dia­ries for the manu­fac­ture of the Arga­tro­ban active ingre­di­ent, the tran­sac­tion was carried out by way of an asset deal. 

Ethy­ph­arm is a leading mid-sized inter­na­tio­nal phar­maceu­ti­cal company with strong Euro­pean roots that manu­fac­tures and supplies essen­tial medi­ci­nes with a focus on hospi­tal care, central nervous system (severe pain and addic­tion) and inter­nal medi­cine. The acqui­si­tion streng­thens Ethy­phar­m’s port­fo­lio of essen­tial medicines. 

In addi­tion to Mitsu­bi­shi Tanabe Pharma Corpo­ra­tion, the sellers were its subsi­dia­ries Mitsu­bi­shi Tanabe Pharma Europe Ltd, London/United King­dom and Mitsu­bi­shi Tanabe Pharma GmbH, Düsseldorf.

Advi­sor Ethy­ph­arm: Schad­bach Rechtsanwälte

Kai Schad­bach, LL.M. (Photo © Schad­bach Rechts­an­wälte, lead), Konstan­tin Warno­wizki and Sören Brost (all M&A), Dr. Petra Weipert and Annette Kuhlen-Leis (both employ­ment law) and Dr. Marco Brand (commer­cial law).

About Schad­bach Attor­neys at Law

Schad­bach Rechts­an­wälte is a natio­nal and inter­na­tio­nal commer­cial law firm based in Frank­furt am Main. Our clients are predo­mi­nantly medium-sized compa­nies and inter­na­tio­nal groups of compa­nies who value our firm’s exper­tise in corpo­rate law as well as our contrac­tual and tran­sac­tional expe­ri­ence, e.g. in the M&A and private equity market. In addi­tion to corporate/M&A, other areas of advice include (inter­na­tio­nal) commer­cial law, direc­tors’ and offi­cers’ liabi­lity and proce­du­ral law. — www.schadbach.com

Subscribe newsletter

Here you can read about the latest transactions, IPOs, private equity deals and venture capital investments, who has raised a new fund, how Buy & Build activities are going.

Get in touch

Contact us!
fyb [at] fyb.de